Inactive Instrument
Converge Global, Inc. Stock Other OTC
Stocks
US21247M2098
Biotechnology & Medical Research
|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| Market Cap | 1.94M 1.73M 1.61M 1.47M 2.77M 187M 2.79M 19.5M 7.59M 95.42M 7.29M 7.13M 307M | P/E 2020 |
-0.33x | P/E 2021 | -0.62x |
|---|---|---|---|---|---|
| Enterprise Value | 5.63M 5.02M 4.68M 4.26M 8.01M 542M 8.07M 56.51M 21.98M 277M 21.12M 20.67M 889M | EV / Sales 2020 |
50.5x | EV / Sales 2021 | 11.9x |
| Free-Float |
-
| Yield 2020 * |
-
| Yield 2021 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Jesús Quintero
CEO | Chief Executive Officer | 64 | 06/12/2019 |
Glen Bonilla
SAM | Sales & Marketing | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jesús Quintero
CHM | Chairman | 64 | - |
Marco Guerrero
BRD | Director/Board Member | 53 | 12/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | ||
| -0.37% | -3.88% | +19.75% | +78.35% | 57.39B | ||
| +1.63% | +0.98% | +3.83% | +38.21% | 47.64B | ||
| +0.50% | +2.94% | +345.86% | +722.17% | 44.29B | ||
| +3.05% | -1.80% | +29.79% | +34.51% | 42.5B | ||
| +1.00% | -1.46% | +4.97% | +111.90% | 40.71B | ||
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | ||
| +1.56% | +4.53% | +31.34% | +26.92% | 28.53B | ||
| +0.76% | -1.45% | -7.15% | -11.12% | 24.34B | ||
| Average | +1.28% | -0.59% | +54.12% | +127.69% | 43.39B | |
| Weighted average by Cap. | +1.52% | -0.84% | +58.31% | +136.94% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 281K 250K 233K 212K 400K 27.03M 403K 2.82M 1.1M 13.8M 1.05M 1.03M 44.34M | 1.03M 919K 856K 779K 1.47M 99.22M 1.48M 10.35M 4.03M 50.64M 3.87M 3.78M 163M |
| Net income | -12.15M -10.83M -10.09M -9.19M -17.3M -1.17B -17.43M -122M -47.45M -597M -45.59M -44.61M -1.92B | -10.19M -9.09M -8.47M -7.71M -14.52M -982M -14.62M -102M -39.82M -501M -38.26M -37.43M -1.61B |
| Net Debt | 1.2M 1.07M 995K 905K 1.7M 115M 1.72M 12.02M 4.68M 58.82M 4.49M 4.4M 189M | 3.69M 3.29M 3.06M 2.79M 5.25M 355M 5.29M 37.01M 14.4M 181M 13.84M 13.54M 582M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















